...its first day of trading Monday. The deal valued Jacobio at HK$10.6 billion ($1.4 billion). Hillhouse Capital...

...Inc. and Biogen Inc. (NASDAQ:BIIB). Jeff Cranmer Overland Pharmaceuticals Allogene Therapeutics Hillhouse Capital chs2020 bee2021...

...focuses on iron deficiency, pain management and respiratory disease.Hillhouse’s Mu and Zhang launch start-up OverlandBacked by Hillhouse Capital...
...to classify and sort cells. TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse Capital Pear...

...Shanghai cancer company during which it has rebooted its C-suite, added dry powder via a Hillhouse Capital-led...

...its coffers through a CD47 licensing deal with AbbVie and a PIPE financing led by Hillhouse Capital.The...

...an investor presentation last week. The biotech named Amgen Inc. (NASDAQ:AMGN), Baker Bros. Advisors and Hillhouse Capital...
...T cell immunoreceptor with Ig and ITIM domains Paul Bonanos, Associate Editor BeiGene Ltd. Amgen Inc. Baker Brothers Advisors Hillhouse Capital chs20...

...Janchor Partners led its $260 million series C-2 equity round, which also included RA Capital, Hillhouse Capital...

...a new indication after raising a $160 million series B round led by existing investor Hillhouse Capital...

...Capital of the Tavistock Group, Tango’s new round includes Cormorant Asset Management, Casdin Capital and Hillhouse Capital...

...The round was jointly led by China venture capital fund, CICC Qide Fund and the Hillhouse Capital...